# Microchip Technology Inc: overview

MCHP · Nasdaq · CIK 827054 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/mchp.md) · [Financials](/companies/mchp/financials.md) · [Filings](/companies/mchp/filings.md) · [Insiders](/companies/mchp/insiders.md)

Latest reported revenue: [$1.48bn](/filings/0000827054-26-000038.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000827054-26-000038).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,164](/filings/0000827054-25-000183.md) | [1,026](/filings/0000827054-26-000009.md) | [971 d](/filings/0000827054-26-000016.md) | [1,076](/filings/0000827054-26-000038.md) | [1,140](/filings/0000827054-25-000183.md) | [1,186](/filings/0000827054-26-000009.md) | [1,311 d](/filings/0000827054-26-000016.md) | [1,485](/filings/0000827054-26-000038.md) |
| Gross margin | % | [57.4%](/filings/0000827054-25-000183.md) | [54.7%](/filings/0000827054-26-000009.md) | [51.6% d](/filings/0000827054-26-000016.md) | [53.6%](/filings/0000827054-26-000038.md) | [55.9%](/filings/0000827054-25-000183.md) | [59.6%](/filings/0000827054-26-000009.md) | [61.0% d](/filings/0000827054-26-000016.md) | [63.2%](/filings/0000827054-26-000038.md) |
| Operating margin | % | [12.6%](/filings/0000827054-25-000183.md) | [3.0%](/filings/0000827054-26-000009.md) | [(10.3%) d](/filings/0000827054-26-000016.md) | [3.0%](/filings/0000827054-26-000038.md) | [7.8%](/filings/0000827054-25-000183.md) | [12.8%](/filings/0000827054-26-000009.md) | [16.6% d](/filings/0000827054-26-000016.md) | [22.7%](/filings/0000827054-26-000038.md) |
| Net margin | % | [6.7%](/filings/0000827054-26-000009.md) | [(5.2%)](/filings/0000827054-26-000009.md) | [(15.9%) d](/filings/0000827054-26-000016.md) | [(1.7%)](/filings/0000827054-26-000038.md) | [3.7%](/filings/0000827054-26-000009.md) | [5.3%](/filings/0000827054-26-000009.md) | [11.0% d](/filings/0000827054-26-000016.md) | [15.5%](/filings/0000827054-26-000038.md) |
| Diluted EPS | $ per share | [0.14](/filings/0000827054-25-000183.md) | [(0.10)](/filings/0000827054-26-000009.md) | not reported | [(0.09)](/filings/0000827054-26-000038.md) | [0.03](/filings/0000827054-25-000183.md) | [0.06](/filings/0000827054-26-000009.md) | not reported | [0.37](/filings/0000827054-26-000038.md) |
| Free cash flow | $m | [22.8 d](/filings/0000827054-25-000183.md) | [253 d](/filings/0000827054-26-000009.md) | [192 d](/filings/0000827054-26-000016.md) | [258](/filings/0000827054-26-000038.md) | [51.6 d](/filings/0000827054-25-000183.md) | [319 d](/filings/0000827054-26-000009.md) | [243 d](/filings/0000827054-26-000016.md) | [498](/filings/0000827054-26-000038.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,821](/filings/0000827054-24-000098.md) | [8,439](/filings/0000827054-25-000077.md) | [7,634](/filings/0000827054-26-000016.md) | [4,402](/filings/0000827054-26-000016.md) | [4,713](/filings/0000827054-26-000016.md) |
| Gross margin | % | [65.2%](/filings/0000827054-24-000098.md) | [67.5%](/filings/0000827054-25-000077.md) | [65.4%](/filings/0000827054-26-000016.md) | [56.1%](/filings/0000827054-26-000016.md) | [57.7%](/filings/0000827054-26-000016.md) |
| Operating margin | % | [27.1%](/filings/0000827054-24-000098.md) | [36.9%](/filings/0000827054-25-000077.md) | [33.7%](/filings/0000827054-26-000016.md) | [6.7%](/filings/0000827054-26-000016.md) | [10.4%](/filings/0000827054-26-000016.md) |
| Net margin | % | [18.8%](/filings/0000827054-24-000098.md) | [26.5%](/filings/0000827054-25-000077.md) | [25.0%](/filings/0000827054-26-000016.md) | [(0.0%)](/filings/0000827054-26-000016.md) | [4.9%](/filings/0000827054-26-000016.md) |
| Diluted EPS | $ per share | [2.27](/filings/0000827054-24-000098.md) | [4.02](/filings/0000827054-25-000077.md) | [3.48](/filings/0000827054-26-000016.md) | [(0.01)](/filings/0000827054-26-000016.md) | [0.22](/filings/0000827054-26-000016.md) |
| Free cash flow | $m | [2,473](/filings/0000827054-24-000098.md) | [3,135](/filings/0000827054-25-000077.md) | [2,608](/filings/0000827054-26-000016.md) | [772](/filings/0000827054-26-000016.md) | [871](/filings/0000827054-26-000016.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mchp/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $5.80bn | 63,586,448 |  | Added +9,256,216 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.23bn | 35,362,807 |  | Added +237,734 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $3.02bn | 33,078,712 |  | Added +673,333 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.63bn | 28,851,673 |  | Added +821,147 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $2.31bn | 25,329,931 |  | Added +10,924,617 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.41bn | 15,540,542 |  | Added +986,380 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $1.32bn | 14,522,587 |  | Reduced −224,949 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $1.08bn | 11,895,608 |  | Added +493,403 |
| [ALKEON CAPITAL MANAGEMENT LLC](/funds/1230239.md) | 2026-06-30 | $1.08bn | 11,892,000 | Call | Added +4,892,000 |
| [Aristotle Capital Management, LLC](/funds/860644.md) | 2026-06-30 | $985.0m | 10,800,194 |  | Reduced −841,774 |

## Recent filings

[All 2,633 filings](/companies/mchp/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 14:57 ET | [8-K](/filings/0000827054-26-000042.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000827054-26-000042 |
| 2026-08-06 | 16:21 ET | [10-Q](/filings/0000827054-26-000038.md) | Quarterly report, period 2026-06-30 | 0000827054-26-000038 |
| 2026-08-06 | 16:17 ET | [8-K](/filings/0000827054-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000827054-26-000037 |
| 2026-07-24 | 16:16 ET | [8-K](/filings/0000827054-26-000031.md) | 5.02 Departure or appointment of officers or directors | 0000827054-26-000031 |
| 2026-07-06 | 16:03 ET | [DEF 14A](/filings/0000827054-26-000026.md) | Proxy statement, period 2026-08-18 | 0000827054-26-000026 |
| 2026-06-01 | 16:18 ET | [8-K](/filings/0000827054-26-000020.md) | 5.02 Departure or appointment of officers or directors | 0000827054-26-000020 |
| 2026-05-21 | 16:40 ET | [10-K](/filings/0000827054-26-000016.md) | Annual report, period 2026-03-31 | 0000827054-26-000016 |
| 2026-05-07 | 16:19 ET | [8-K](/filings/0000827054-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000827054-26-000012 |
| 2026-02-11 | 16:41 ET | [8-K](/filings/0001193125-26-046713.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-046713 |
| 2026-02-05 | 16:19 ET | [10-Q](/filings/0000827054-26-000009.md) | Quarterly report, period 2025-12-31 | 0000827054-26-000009 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0000827054-26-000016.md), filed May 21, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/376741ee-3866-448b-98c2-6562bba12488)

## About the filer

- CIK: 827054
- Tickers: MCHP, MCHPP
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.